Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters

AIDS Research and Human Retroviruses

Volumn 29, Issue 1, 2013, Pages 164-171

  Lingappa, Jairam R ^a,b   Thomas, Katherine K ^a   Hughes, James P ^a   Baeten, Jared M ^a   Wald, Anna ^a,c   Farquhar, Carey ^a   De Bruyn, Guy ^d   Fife, Kenneth H ^e   Campbell, Mary S ^a   Kapiga, Saidi ^f   Mullins, James I ^a   Celum, Connie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e INDIANA UNIVERSITY   (United States)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CIRCUMCISION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SEXUAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; CIRCUMCISION, MALE; FEMALE; HERPES GENITALIS; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; RISK FACTORS; RNA, VIRAL; SEX FACTORS; SEXUAL PARTNERS; TIME FACTORS; VIRAL LOAD;

EID: 84871895606     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0206     Document Type: Article

References (50)

1. Mellors JW, Rinaldo CR Jr, Gupta P, et al.: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272(5265):1167-1170.
2. Quinn TC, Wawer MJ, Sewankambo N, et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342(13):921-929.
3. Lavreys L, Baeten JM, Chohan V, et al.: Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis 2006;42(9):1333-1339.
4. Goulder PJ, Bunce M, Krausa P, et al.: Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses 1996;12(18):1691-1698.
5. Altfeld M, Addo MM, Rosenberg ES, et al.: Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003;17(18):2581-2591.
6. Carrington M, Nelson GW, Martin MP, et al.: HLA and HIV- 1: Heterozygote advantage and B, 35-Cw, 04 disadvantage. Science 1999;283(5408):1748-1752.
7. Fellay J, Ge D, Shianna KV, et al.: Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009;5(12): e1000791.
8. Fellay J, Shianna KV, Ge D, et al.: A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317(5840):944-947.
9. Kaslow RA, Carrington M, Apple R, et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2(4): 405-411.
10. Pelak K, Goldstein DB, Walley NM, et al.: Host determinants of HIV-1 control in African Americans. J Infect Dis 2010; 201(8):1141-1149.
11. Tang J, Tang S, Lobashevsky E, et al.: HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res Hum Retroviruses 2004; 20(1):19-25.
12. Hecht FM, Hartogensis W, Bragg L, et al.: HIV RNA level in early infection is predicted by viral load in the transmission source. AIDS 2010;24(7):941-945.
13. Hollingsworth TD, Laeyendecker O, Shirreff G, et al.: HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda. PLoS Pathog 2010;6(5):e1000876.
14. van der Kuyl AC, Jurriaans S, Pollakis G, et al.: HIV RNA levels in transmission sources only weakly predict plasma viral load in recipients. AIDS 2010;24(10):1607-1608.
15. Alizon S, von Wyl V, Stadler T, et al.: Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog 2010;6(9).
16. Fraser C and Hollingsworth TD: Interpretation of correlations in setpoint viral load in transmitting couples. AIDS 2010;24(16):2596-2597.
17. Celum C, Wald A, Lingappa JR, et al.: Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010;362:427-439.
18. Lingappa JR, Baeten JM, Wald A, et al.: Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: A randomised placebo- controlled trial. Lancet 2010;375(9717):824-833.
19. Campbell M, Mullins J, Hughes J, et al.: Identifying the transmitted virus: Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One 2011;6(3):e16986.
20. Cohen CR, Lingappa JR, Baeten JM, et al.: Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: A prospective cohort analysis among African couples. PLoS Med 2012;9(6):e1001251.
21. Lavreys L, Baeten JM, Kreiss JK, et al.: Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis 2004;189(2):303-311.
22. Busch MP, Lee LL, Satten GA, et al.: Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1995; 35(2):91-97.
23. Lingappa J, Kahle E, Mugo N, et al.: Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: The Partners Study. PLoS One 2009;4(4):e5272.
24. Baeten JM, Donnell D, Kapiga SH, et al.: Male circumcision and risk of male-to-female HIV-1 transmission: A multinational prospective study in African HIV-1-serodiscordant couples. AIDS 2010;24(5):737-744.
25. Gray RH, Kiwanuka N, Quinn TC, et al.: Male circumcision and HIV acquisition and transmission: Cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 2000;14(15):2371-2381.
26. Kapiga SH, Lyamuya EF, Lwihula GK, et al.: The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 1998;12(1):75-84.
27. Prodger JL, Gray R, Kigozi G, et al.: Foreskin T-cell subsets differ substantially from blood with respect to HIV coreceptor expression, inflammatory profile, and memory status. Mucosal Immunol 2012;5(2):121-128.
28. Rebbapragada A, Howe K, Wachihi C, et al.: Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 2008;49(5):520-522.
29. Coleman JS, Hitti J, Bukusi EA, et al.: Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007;21(6):755-759.
30. Sha BE, Zariffard MR, Wang QJ, et al.: Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005;191(1):25-32.
31. Tanton C, Weiss HA, Le Goff J, et al.: Correlates of HIV-1 genital shedding in Tanzanian women. PloS One 2011;6(3): e17480.
32. Moreira C, Venkatesh KK, DeLong A, et al.: Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: A pilot study. Clin Infect Dis 2009;49(6):991-992.
33. Wang CC, McClelland RS, Reilly M, et al.: The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001;183(7):1017-1022.
34. Price LB, Liu CM, Johnson KE, et al.: The effects of circumcision on the penis microbiome. PloS One 2010;5(1):e8422.
35. Tobian AA, Kigozi G, Gravitt PE, et al.: Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. AIDS 2012;26(12): 1555-1565.
36. Gray RH, Kigozi G, Serwadda D, et al.: Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet 2007;369(9562):657-666.
37. Sobngwi-Tambekou J, Taljaard D, Lissouba P, et al.: Effect of HSV-2 serostatus on acquisition of HIV by young men: Results of a longitudinal study in Orange Farm, South Africa. J Infect Dis 2009;199(7):958-964.
38. Palu G, Benetti L, and Calistri A: Molecular basis of the interactions between herpes simplex viruses and HIV-1. Herpes 2001;8(2):50-55.
39. Lisco A, Vanpouille C, Tchesnokov EP, et al.: Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirusinfected human tissues. Cell Host Microbe 2008;4(3):260-270.
40. McMahon MA, Siliciano JD, Lai J, et al.: The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation. J Biol Chem 2008;283(46):31289-31293.
41. Baeten JM, Lingappa J, Beck I, et al.: Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons. J Infect Dis 2011;203(1):117-121.
42. Baeten JM, Kahle E, Lingappa JR, et al.: Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011;3(77):77ra29.
43. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al.: Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008;105(21):7552-7557.
44. Novitsky V, Wang R, Margolin L, et al.: Transmission of single and multiple viral variants in primary HIV-1 subtype C infection. PloS One 2011;6(2):e16714.
45. Suy A, Castro P, Nomdedeu M, et al.: Immunological profile of heterosexual highly HIV-exposed uninfected individuals: Predominant role of CD4 and CD8 T-cell activation. J Infect Dis 2007;196(8):1191-1201.
46. Haase AT: Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 2011;62:127-139.
47. Addo MM, Altfeld M, Brainard DM, et al.: Lack of detectable HIV-1-specific CD8 (+) T cell responses in Zambian HIV-1- exposed seronegative partners of HIV-1-positive individuals. J Infect Dis 2011;203(2):258-262.
48. Restrepo C, Rallon NI, del Romero J, et al.: Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals. J Immunol 2010;185(2):982-989.
49. Tang J, Costello C, Keet IP, et al.: HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1999; 15(4):317-324.
50. Gray RH, Li X, Wawer MJ, et al.: Determinants of HIV-1 load in subjects with early and later HIV infections, in a generalpopulation cohort of Rakai, Uganda. J Infect Dis 2004; 189(7):1209-1215.